Helicobacter pylori. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: the treatment group are pretreated with NAC groups underfor the 600 mg 2 times a day for a week and then standard triple therapy (amoxicillin 1000 mg 2 times a day, clarithromycin 500
Treatment - Drugs
the treatment group are pretreated with NAC groups underfor the 600 mg 2 times a day for a week and then standard triple therapy (amoxicillin 1000 mg 2 times a day, clarithromycin 500 mg two times dai
Control group treated with standard triple therapy (amoxicillin 1000 mg 2 times a day, clarithromycin 500 mg two times daily and omeprazole 20 mg 2 times a day) are placed.
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients older than 20 years old, HP positive patients at the time of an injection molded pylori eradication indicated they have not previously received eradication regimen, the patients who have NAC in past month. Exclusion criteria: history of gastrectomy, gastric cancer includes adenocarcinoma, previous allergic reaction to antibiotics (amoxicillin and clarithromycin), NAC and proton pump inhibitors (omeprazole), pregnant and lactating women, concurrent severe illness, phenyl ketone Avery, taking antibiotics or NAC now or in the past month and is patient's dissatisfaction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of H pylori eradication regimen. Timepoint: One month after treatment. Method of measurement: Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Korosh Masnadi Shirazi
Tabriz University of Medical Sciences
Outcome results
None listed